Helping you find new business opportunities
Realise your business objectives by working with us. With 96 per cent of Macquarie University’s research disciplines rated at world standard or higher (Excellence in Research for Australia, 2015), we can help you create solutions that are informed by some of the world’s most innovative thinking.
We offer flexible solutions through every stage of the innovation and commercialisation process. Our objective is to achieve win-win deals.
Contact us to discuss your individual needs, or explore our current licencing opportunities below.
Glaucoma prevention and treatment: Novel therapeutic strategy to reduce RGC damage and disease progression
A novel and disease-modifying approach delivers a mutant neuroserpin molecule that has shown significant protection against glaucoma damage, including RGC degeneration.
DEEPSLICE: A.I. solution for registration of mouse brain images
DeepSlice is trained to predict Output Vectors, corresponding to Allen Mouse Brain Atlas coordinates, from coronal histological images prepared using any staining or imaging technique.
High brightness pulsed Raman laser
Using diamond Raman technology, a pump beam can be efficiently converted to a longer wavelength output beam using 1, 2 or more Stokes shifts of the Raman medium. For example, a 1.06 μm laser pump beam can be efficiently converted to a 1.5 μm output beam.
High average power continuous-wave laser
High thermal conductivity Raman materials such as diamond can be used to mitigate thermal lensing enabling operation over a very wide power range without compromising output beam quality.
Diamond-based High Energy Laser (HEL) tech
Macquarie’s diamond-based High Energy Laser (HEL) tech runs at an eye safer 1.24 µm, with unprecedented ultra-high power potential of 100’s of kW to MWs. This technology is transformative as beam-conversion in diamond can substantially raise the power barrier.
Continuous-wave yellow Raman laser
Design of continuous-wave Raman lasers, particularly yellow.
Twisted light multiplexer and demultiplexer
Our OAM light modulator integrates an ultrahigh capacity OAM-multiplexing metasurface with ultrafast laser-inscribed photonic waveguides, leading to the world’s first all-on-chip OAM light modulator that uses waveguide inputs and outputs to generate and detect OAM modes.
Iterative compressive sensing direction of arrival estimation (icsDOA)
Iterative compressive sensing direction of arrival estimation (icsDOA) is the most advanced technology to determine the location of origin for radio, radar or sonar.
Power amplifier with inbuilt thermal sensor
This electronic real-time monitoring system enables microsecond accurate measurements of the temperature of a transistor.
Multi-level metallisation thru-wafer transformer and bias feed network for microwave circuits
The elimination of airbridge structures improves bandwidth and reduces the overall size.
A novel enhancement of the FET mixer concept for GaN FETs with field-plate technology.
Capillary forced induced nanowelding in metal oxide 3D nanostructures
A capillary-force-driven methodology enhancing nanoparticle cohesion to improve the electrical conductivity of nanostructured metal-oxide gas sensors.
A method for lamination of solar cells
An alternative method of lamination by directly heating the solar cell for improved efficiency.
A method for delaminating solar cells
A method for delaminating photovoltaic modules without energy-intensive processes or using toxic chemicals.
Effective, safe and novel insect repellent for use in crop protection
A novel repellent effective against several fruit fly species.
Heterologous expression of functional fungal laccase in animals for bioremediation of environmental pollutants
Utilising low-cost organic waste streams as feedstocks and simplified infrastructure for biomanufacturing with minimal use of water.
Chemistry and Biomolecular Science
Efficient Biodegradation of Plastics using Synthetic Organisms
Genetically engineered microbial (yeast or bacterial) synthetic strains which will be utilised for enhanced PE degradation and subsequent chemical commodity production (including but without limitation to biofuels, nutrient sources and fertilizers).
Contact our experts
Kathryn Sunn, Director Commercialisation
Kathryn joined Macquarie University at the beginning of 2023 in the role of Director, Commercialisation.
Kathryn brings a diverse background in commercialisation combined with broad technical expertise and an extensive network across the scientific, industry, commercialisation and investor communities.
With over 20 years of experience in Intellectual Property, IP strategy, commercialisation and business development acquired from roles in two of Australia’s top tier patent firms and Australia’s two largest Universities, Kathryn has established a track record in maximising impact from strategic partnerships and providing pragmatic, commercially focused advice in the translation of IP.
Kathryn has a medical science background with a major in genetics, gaining her PhD from the Garvan Institute of Medical Research. She is a registered patent and trade mark attorney in Australia and New Zealand and an experienced Board Director, previously serving on the Boards of Cicada Innovations, Knowledge Commercialisation Australasia (KCA) and several startup companies, as well as the Investment Committee of Uniseed.
T: +61 (2) 9850 4127 | M: +61 (0)481 477 412
Gorjana Mitic, Commercialisation and Innovation Manager
Gorjana joined Macquarie University as a Commercialisation and Innovation Manager in January 2018. She works closely with researchers in life sciences and medicine to assess innovative technologies and facilitate their translation and commercialisation through strategic partnerships, licensing and industry collaborations.
Prior to this role, she was a Business Development Manager at a biotechnology commercialisation consultancy Bio-Link Australia for 4 years. She worked with biotechnology and pharmaceutical companies and Medical Research Institutes to develop IP and commercialisation strategy, secure partnerships and negotiate licensing deals. She also provided comprehensive reviews of regulatory, competitive and IP landscapes.
Prior to receiving her PhD at the Children’s Cancer Institute from the University of NSW (Faculty of Medicine), Gorjana completed a BSc (Biotechnology) with First-Class Honours. Her PhD thesis investigated new molecular targets in glioblastoma, a devastating brain cancer. In 2013, Gorjana was awarded a prestigious Women in Cancer Research Scholar Award. Concurrently, Gorjana obtained a Diploma of Innovation Management at UNSW focusing on the biotechnology industry, commercialisation, technology transfer and IP management. She served as an active committee member and a UNSW student representative of the AusBiotech Student Association for several years.
She is currently a mentor and an alumna of the Bridge Program, a government and industry supported training program for science commercialisation and pharmaceutical drug development.
Gorjana also represents Macquarie University and MQ Health as a member of the Medical Research Commercialisation Fund (MRCF) Investment Research Committee.
Gorjana has an extensive industry network and loves creating opportunities for researchers to collaborate with industry. Thrilled by innovative scientific discoveries and compelling data, Gorjana is always pleased to assist researchers and find ways towards translation and impact.
Phone: +61 2 9850 4542 | M: +61 (0)439 094 133
Bel Coppock, Intellectual Property Portfolio Manager
Bel has a diverse background in events, regional marketing, customer service and patent management. Bel is responsible for keeping the Office of Commercialisation organised. She also liaises with Macquarie University's existing pool of inventors and administers royalty payments.
If you have any questions about the commercialisation process at Macquarie University, please talk to Bel.
Phone: +61 2 9850 4598
Content owner: Commercialisation and Innovation Last updated: 16 Mar 2023 6:22pm